Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells1

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Immunology

• Publication date

  2004-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.173.2.1444PMID 15240741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulatory T cells

  2006cited by this paper
• Cancer vaccines

  2005cited by this paper
• T regulatory cells.

  2005cited by this paper
• Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.

  2004cited by this paper
• Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma.

  2004cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma.

  2003cited by this paper
• Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State

  2003influential reference
• An essential role for Scurfin in CD4+CD25+ T regulatory cells

  2003cited by this paper
• CD4+CD25+ Suppressor Lymphocytes in the Circulation of Patients Immunized Against Melanoma Antigens

  2003cited by this paper
• Costimulation of T cells by OX40, 4-1BB, and CD27.

  2003influential reference
• Foxp3 and natural regulatory T cells: key to a cell lineage?

  2003cited by this paper
• Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

  2003cited by this paper
• Supporting Online Material

  2003cited by this paper
• T-cell responses of vaccinated cancer patients.

  2003cited by this paper
• Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes.

  2003cited by this paper
• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

  2002cited by this paper
• Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta.

  2002cited by this paper
• Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes

  2002cited by this paper
• Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells

  2002cited by this paper
• Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T Cells

  2002cited by this paper
• CD4+CD25+ suppressor T cells: more questions than answers

  2002influential reference
• Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1

  2002cited by this paper
• Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1

  2002cited by this paper
• Infectious Tolerance

  2002cited by this paper
• CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

  2002cited by this paper
• In Vitro Generation of Interleukin 10–producing Regulatory CD4+ T Cells Is Induced by Immunosuppressive Drugs and Inhibited by T Helper Type 1 (Th1)– and Th2-inducing Cytokines

  2002cited by this paper
• Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses.

  2002cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001influential reference
• Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood

  2001cited by this paper
• Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

  2001cited by this paper
• A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.

  2001cited by this paper
• Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells

  2001cited by this paper
• CCR7 Expression and Memory T Cell Diversity in Humans1

  2001cited by this paper
• Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood

  2001cited by this paper
• CD4+CD25high Regulatory Cells in Human Peripheral Blood1

  2001cited by this paper
• Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells

  2001cited by this paper
• Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

  2001cited by this paper
• Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β

  2001cited by this paper
• Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

  2001cited by this paper
• Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function

  2001cited by this paper
• Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro

  2001cited by this paper
• Type 1 T regulatory cells

  2001cited by this paper
• Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis‐prone population

  2001cited by this paper
• Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.

  2001cited by this paper
• A Role for TGF-β in the Generation and Expansion of CD4+CD25+ Regulatory T Cells from Human Peripheral Blood1

  2001cited by this paper
• Regulatory T cells: key controllers of immunologic self-tolerance.

  2000cited by this paper
• Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells

  2000cited by this paper
• The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells

  2000cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

  1999cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody

  1999cited by this paper
• Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes

  1998influential reference
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

  1998cited by this paper
• Cancer vaccines

  1998cited by this paper
• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

  1998cited by this paper
• Infectious tolerance.

  1998cited by this paper
• Tumor antigens recognized by T cells.

  1997influential reference
• The Antigen t Cell Receptor: Selected Protocols and Applications

  1997cited by this paper
• A Model for Developmentally Acquired Thymus‐Dependent Tolerance to Central and Peripheral Antigens

  1996cited by this paper
• Melanoma-associated expression of transforming growth factor-beta isoforms.

  1996cited by this paper
• Interleukin 10 production by human melanoma.

  1996cited by this paper
• Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

  1996cited by this paper
• Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

  1995cited by this paper
• Antigen-selected T-cell receptor diversity and self-nonself homology.

  1993cited by this paper
• "Infectious" transplantation tolerance

  1993cited by this paper
• Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma

  1989cited by this paper
• Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.

  1986cited by this paper
• Concomitant tumor immunity and the resistance to a second tumor challenge.

  1983cited by this paper
• Spontaneous regression of malignant melanoma: a review of the literature on incidence, clinical features, and possible mechanisms.

  1976cited by this paper

• From Immunobiology to Clinical Application: Tumor-Infiltrating Lymphocytes in Melanoma

  2026cites this paper
• Tumor Microenvironment in Glioblastoma: The Central Role of the Hypoxic-Necrotic Core.

  2025cites this paper
• The multi-faceted immune modulatory role of S100A4 in cancer and chronic inflammatory disease

  2025cites this paper
• Bioengineering Platelets Presenting PD‐L1, Galectin‐9 and BTLA to Ameliorate Type 1 Diabetes

  2025cites this paper
• Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It

  2025cites this paper
• Advancing immunotherapy for melanoma: the critical role of single-cell analysis in identifying predictive biomarkers

  2024cites this paper
• Macrophages promote pre-metastatic niche formation of breast cancer through aryl hydrocarbon receptor activity

  2024cites this paper
• The impact of elective cervical lymph node treatment on the tumour immune response in head and neck squamous cell carcinoma: time for a change in treatment strategy?

  2024cites this paper
• Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit

  2024cites this paper
• Tumor infiltrating lymphocytes recognition in primary melanoma by deep learning convolutional neural network.

  2023cites this paper
• T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms

  2023cites this paper
• Mechanisms of Altered Immune Response in Skin Melanoma

  2023cites this paper
• Alleviating hypoxia to improve cancer immunotherapy

  2023cites this paper
• Immune determinants of the pre-metastatic niche.

  2023cites this paper
• Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics

  2022cites this paper
• The Crosstalk Between Adipose-Derived Stem or Stromal Cells (ASC) and Cancer Cells and ASC-Mediated Effects on Cancer Formation and Progression—ASCs: Safety Hazard or Harmless Source of Tropism?

  2022cites this paper
• Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells

  2022cites this paper
• Tertiary lymphoid structure and decreased CD8+ T cell infiltration in minimally invasive adenocarcinoma

  2022cites this paper
• A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance

  2022cites this paper
• Reprogramming of sentinel lymph node microenvironment during tumor metastasis

  2022cites this paper
• The cellular and molecular mediators of metastasis to the lung

  2022cites this paper
• Single-Cell Immune Mapping of Melanoma Sentinel Lymph Nodes Reveals an Actionable Immunotolerant Microenvironment.

  2022cites this paper
• One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma

  2022cites this paper
• Targeting immunosuppression by TGF-β1 for cancer immunotherapy

  2021cites this paper
• Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor

  2021cites this paper
• The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors

  2021cites this paper
• Regulatory T-Cells and Multiple Myeloma: Implications in Tumor Immune Biology and Treatment

  2021cites this paper
• The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis

  2021cites this paper
• Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications.

  2021cites this paper
• Glutamine Metabolism in Cancer.

  2021cites this paper
• Targeting Tumor-Induced Immunosuppression Using Conventional Cancer Therapeutics

  2021cites this paper
• Targeting the tumor microenvironment of Ewing sarcoma.

  2021cites this paper
• T‐cell subsets in the skin and their role in inflammatory skin disorders

  2021cites this paper
• MK‐6, a novel not‐α IL‐2, elicits a potent antitumor activity by improving the effector to regulatory T cell balance

  2021cites this paper
• Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice

  2020cites this paper
• Harnessing cells to deliver nanoparticle drugs to treat cancer.

  2020cites this paper
• FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation

  2020cites this paper
• A review of fasting effects on the response of cancer to chemotherapy.

  2020cites this paper
• The Influence of Tumor Microenvironment on Immune Escape of Melanoma

  2020cites this paper
• The miRNAs Role in Melanoma and in Its Resistance to Therapy

  2020cites this paper
• Regulatory T cell therapy: Current and future design perspectives.

  2020cites this paper
• The presence of tumour-in ltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma

  2020cites this paper
• The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma

  2020cites this paper
• Overcoming Immune Evasion in Melanoma

  2020cites this paper
• Chemo-immunotherapy with doxorubicin prodrug and erythrocyte membrane-enveloped polymer nano-vaccine enhances antitumor activity.

  2020cites this paper
• Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer

  2020cites this paper
• Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia

  2020cites this paper
• Prognostic Value of Tumor-Infiltrating Lymphocytes Differs Depending on Lymphocyte Subsets in Esophageal Squamous Cell Carcinoma: An Updated Meta-Analysis

  2020cites this paper
• Nicotinamide for skin cancer chemoprevention: effects of nicotinamide on melanoma in vitro and in vivo

  2020cites this paper
• The role of tumor infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in hypopharyngeal squamous cell carcinoma

  2020cites this paper
• Current Perspectives, Challenges and Advances in Cell Based Therapies

  2020cites this paper
• Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells

  2020cites this paper
• IL‐16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity

  2020cites this paper
• EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells

  2020cites this paper
• Primary Resistance to PD-1-Based Immunotherapy—A Study in 319 Patients with Stage IV Melanoma

  2020cites this paper
• Tertiary Lymphoid Structure and CD8 T Cell Exclusion in Minimally Invasive Adenocarcinoma

  2020cites this paper
• Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses

  2019cites this paper
• Current controversies in early-stage melanoma: Questions on incidence, screening, and histologic regression.

  2019cites this paper
• Anti-regulatory T cell vaccines in immunotherapy: focusing on FoxP3 as target

  2019cites this paper
• Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression

  2019cites this paper
• PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells

  2019cites this paper
• Innate and Adaptive Immune Responses to Cancer

  2019cites this paper
• Phenotypic characterisation of regulatory T cells in dogs reveals signature transcripts conserved in humans and mice

  2019cites this paper
• Turning the Tide Against Regulatory T Cells

  2019cites this paper
• Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles

  2019cites this paper
• Effect of Apatinib on Serum CD4+CD25+ T cells, NK Cells, and T Cells Subgroup in Malignant Tumor

  2019cites this paper
• Dynamic regulation of CD4+ regulatory T cells by radiation treatment

  2019cites this paper
• Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.

  2019cites this paper
• BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade.

  2019cites this paper
• Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance

  2019cites this paper
• Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer

  2018cites this paper
• Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis

  2018cites this paper
• Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells

  2018cites this paper
• The hypoxic tumour microenvironment

  2018cites this paper
• Imiquimod 5% cream as a therapeutic option for extramammary Paget's disease

  2018cites this paper
• Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions

  2018cites this paper
• Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma

  2018cites this paper
• Lymph Node Cellular Dynamics in Cancer and HIV: What Can We Learn for the Follicular CD4 (Tfh) Cells?

  2018cites this paper
• Metastatic niche functions and therapeutic opportunities

  2018cites this paper
• Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma

  2018cites this paper
• Skin Cancers Associated with Lymphoid Malignancies

  2018cites this paper
• Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going

  2018cites this paper
• FOXP3 expression is modulated by TGF-β1/NOTCH1 pathway in human melanoma

  2018cites this paper
• Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness

  2018cites this paper
• Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas.

  2018cites this paper
• CD4 and CD8 T lymphocyte interplay in controlling tumor growth

  2017cites this paper
• Topical treatment of all‐trans retinoic acid inhibits murine melanoma partly by promoting CD8+ T‐cell immunity

  2017cites this paper
• Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence

  2017cites this paper
• Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma.

  2017cites this paper
• The tumor-draining lymph nodes are immunosuppressed in patients with hepatocellular carcinoma

  2017cites this paper
• Peripheral Tr1 and Foxp3+ Treg as Markers of Recurrent Malignancies in Patients with Hepato-Biliary Pancreatic Cancers.

  2017cites this paper
• Regulation of tumor progression and metastasis by bone marrow-derived microenvironments

  2017cites this paper
• Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor

  2017cites this paper
• Overview of Interferon: Characteristics, signaling and anti-cancer effect

  2017cites this paper
• Changes in regulatory T cells in dogs with B-cell lymphoma and association with clinical tumour stage

  2017cites this paper
• Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells

  2017cites this paper
• Chloroquine (CQ) exerts anti‐breast cancer through modulating microenvironment and inducing apoptosis

  2017cites this paper
• Epidrugs in the Immunotherapy of Cutaneous and Uveal Melanoma.

  2017cites this paper
• The Role of Tumor Microenvironment in Cancer Immunotherapy.

  2017cites this paper
• Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients

  2017cites this paper